DCM
PRVB
DG Capital Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-499,271
| Closed | -$2.25M | – | 42 |
|
|
2022
Q3 | $2.25M | Sell |
499,271
-123,297
| -20% | -$555K | 0.99% | 16 |
|
|
2022
Q2 | $2.49M | Buy |
622,568
+100,000
| +19% | +$400K | 0.89% | 18 |
|
|
2022
Q1 | $3.83M | Sell |
522,568
-97,139
| -16% | -$711K | 0.77% | 29 |
|
|
2021
Q4 | $3.48M | Buy |
619,707
+75,485
| +14% | +$424K | 0.57% | 29 |
|
|
2021
Q3 | $3.48M | Buy |
+544,222
| New | +$3.48M | 0.71% | 33 |
|
|
2021
Q1 | – | Sell |
-443,331
| Closed | -$7.51M | – | 132 |
|
|
2020
Q4 | $7.51M | Buy |
443,331
+26,239
| +6% | +$444K | 3.18% | 12 |
|
|
2020
Q3 | $5.35M | Buy |
417,092
+129,920
| +45% | +$1.67M | 3.22% | 13 |
|
|
2020
Q2 | $4.05M | Buy |
+287,172
| New | +$4.05M | 3.32% | 14 |
|